Aesthetic Procedures

XEOMIN®

What Is XEOMIN®?

XEOMIN® is a prescription medication used in facial aesthetics to temporarily improve the appearance of moderate to severe glabellar frown lines between the eyes (glabellar lines) in adults.

XEOMIN® contains botulinum toxin type A, a protein purified from the bacterium Clostridium botulinum.

XEOMIN® is also sometimes referred to as incobotulinumtoxinA.

How Does It Work?

When you squint or frown, the muscles between your brows contract, causing the skin to furrow and fold. These lines that occur due to facial mimics are referred to as dynamic lines. Over time, as your skin ages and loses some of its elasticity, these repeated contractions can cause persistent frown lines.

Botulinum toxin type A – the active ingredient in XEOMIN® – is used in facial aesthetic treatment to treat dynamic lines like glabellar frown lines. It acts on nerve endings in muscles to prevent muscle fibers from contracting. By reducing these contractions, XEOMIN® can temporarily reduce the lines between your eyebrows, crows feet, and on your forehead.

Am I a Candidate for Xeomin®?

If you have frown lines and no history of an adverse reaction from neuromodulators, you may be a good candidate for Xeomin® injections. Dr. Gillespie may recommend a more extensive method of correcting your frown lines if he determines that your skin laxity may diminish the results of your Xeomin® treatment.

How is Xeomin® Performed?

Xeomin® is an injectable product that is administered via needle. The product is injected at several points along the muscles that control your facial expressions. The needle is very small, and you may feel only a slight prick on your skin. If you find that the procedure is too uncomfortable, we can use a topical anesthesia to help you relax.

How long do the results last?

In most cases, the results of Xeomin® injections last three to four months, but we have seen the results last as long as six months. Dr. Gillespie will schedule follow-up appointments with one of our aestheticians to monitor the results and decide the best time for a follow-up treatment.